90389-19-8 Usage
Uses
Used in Pharmaceutical Industry:
1-(3,4-Dichlorophenyl)-N-MethylMethanaMine hydrochloride is used as a pharmaceutical intermediate for its role in the synthesis of various organic compounds. Its potent central nervous system stimulant properties and structural features make it a valuable component in the development of new medications.
Used in Research and Development:
In the research and development sector, 1-(3,4-Dichlorophenyl)-N-MethylMethanaMine hydrochloride serves as a crucial research chemical. Its unique properties and structural characteristics allow scientists to study its potential applications in the treatment of neurological and psychiatric disorders, contributing to the advancement of medical knowledge and the development of novel therapeutic strategies.
Used in Drug Formulation:
Due to its high solubility in water and crystalline solid form, 1-(3,4-Dichlorophenyl)-N-MethylMethanaMine hydrochloride is used in the formulation of pharmaceutical drugs. Its properties make it suitable for incorporation into various drug delivery systems, enhancing the bioavailability and therapeutic outcomes of the medications it is a part of.
Check Digit Verification of cas no
The CAS Registry Mumber 90389-19-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 9,0,3,8 and 9 respectively; the second part has 2 digits, 1 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 90389-19:
(7*9)+(6*0)+(5*3)+(4*8)+(3*9)+(2*1)+(1*9)=148
148 % 10 = 8
So 90389-19-8 is a valid CAS Registry Number.
90389-19-8Relevant academic research and scientific papers
AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIGANDS
-
Page/Page column 21, (2010/11/26)
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I) and their salts, solvates and isomers, to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers and to the new intermediates of the general formula (III).
AMINO-ALKYL-AMIDE DERIVATIVES AS CCR3 RECEPTOR LIGANDS
-
Page/Page column 17, (2010/11/26)
The present invention relates to the CCR3 receptor ligands of the general formula (I), within them favourably to antagonists and to the salts, solvates and isomers thereof, to the pharmaceutical compositions containing them, to the use of the compounds of the general formula (I) and their salts, solvates and isomers and to the preparation of the compounds of the general formula (I) and their salts, solvates and isomers and to the new intermediates of the general formula (XX) and (XXI).
